EUVIMEDEUVIMED entdecken
Open Access

Risk Factors for Thrombocytopenia Induced by Capecitabine Plus Oxaliplatin Therapy in Patients With Colorectal Cancer

Nanami Kato, Tsuyoshi Nakai, Sachiyo Kodama, Sachiko Koyama, Shigeki Nakane, Yasuhiro Wada, Hiroshi Oda, Hiromi Katayama, Hiroki Mase, Yasuhiro Miyagawa, Masayuki Miyazaki, Shigeki Yamada und 1 weitere

In Vivo · 2024

DOI: 10.21873/invivo.13561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Nanami Kato und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, Nagoya University Hospital, Nagoya, Japan. Hauptthemen laut MEDLINE: Capecitabine, Thrombocytopenia, Oxaliplatin, Colorectal Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapecitabineThrombocytopeniaOxaliplatinColorectal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleAgedMiddle AgedRisk FactorsPlatelet CountRetrospective StudiesAged, 80 and overAdult

Stichwörter der Autor:innen

Colorectal cancer patientscapecitabine plus oxaliplatin therapyrisk factorthrombocytopenia

Substanzen

CapecitabineOxaliplatin

Autor:innen und Institutionen

  • Department of Hospital Pharmacy, Nagoya University Hospital, Nagoya, Japan.
  • Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Toyoake, Japan.
  • Department of Pharmacy, Konan Kosei Hospital, Konan, Japan.
  • Department of Pharmacy, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
  • Department of Pharmacy, Japan Community Health care Organization Chukyo Hospital, Nagoya, Japan.
  • Department of Pharmacy, Nishichita General Hospital, Tokai, Japan.

Zitieren

APA

Kato, N., Nakai, T., Kodama, S., Koyama, S., Nakane, S., Wada, Y., Oda, H., Katayama, H., Mase, H., Miyagawa, Y., Miyazaki, M., Yamada, S., & Yamada, K. (2024). Risk Factors for Thrombocytopenia Induced by Capecitabine Plus Oxaliplatin Therapy in Patients With Colorectal Cancer. In Vivo. https://doi.org/10.21873/invivo.13561

Vancouver

Kato N, Nakai T, Kodama S, Koyama S, Nakane S, Wada Y, et al. Risk Factors for Thrombocytopenia Induced by Capecitabine Plus Oxaliplatin Therapy in Patients With Colorectal Cancer. In Vivo. 2024. doi:10.21873/invivo.13561

BibTeX
@article{Kato2024,
  author = {Kato, Nanami and Nakai, Tsuyoshi and Kodama, Sachiyo and Koyama, Sachiko and Nakane, Shigeki and Wada, Yasuhiro and Oda, Hiroshi and Katayama, Hiromi and Mase, Hiroki and Miyagawa, Yasuhiro and Miyazaki, Masayuki and Yamada, Shigeki and Yamada, Kiyofumi},
  title = {Risk Factors for Thrombocytopenia Induced by Capecitabine Plus Oxaliplatin Therapy in Patients With Colorectal Cancer},
  journal = {In Vivo},
  year = {2024},
  doi = {10.21873/invivo.13561}
}
Kostenlos starten →